by Bob Yirka, Medical Xpress A model showing Alda-1 bound to ALDH2, with the catalytic tunnel of ALDH2 enlarged (B). Credit: H. Guo, et al., Science Translational Medicine (2023) A team of researchers at Stanford University working with two colleagues from Greenstone Biosciences has found that an SGLT2 inhibitor can reduce endothelial dysfunction commonly associated with the ALDH2 alcohol...